Fol. Biol. 2012, 58, 64-68

https://doi.org/10.14712/fb2012058020064

Mutational Analysis of the NPHS2 Gene in Czech Patients with Idiopathic Nephrotic Syndrome

Jana Reiterová1,2, H. Šafránková1, L. Obeidová2, J. Štekrová1,2, D. Maixnerová1, M. Merta2,3, V. Tesař1

1Department of Nephrology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
2Institute of Biology and Human Genetics, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic
3Department of Metabolic Care and Gerontology, University Hospital in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic

Received October 2011
Accepted January 2012

References

1. Akilesh, S., Suleiman, H., Yu, H., Stander, M. C., Lavin, P. (2011) Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121, 4127-4137. <https://doi.org/10.1172/JCI46458>
2. Aucella, F., De Bonis, P., Gatta, G., Bisceglia, L. (2005) Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron Clin. Pract. 99, 31-36. <https://doi.org/10.1159/000082864>
3. Boute, N., Gribouval, O., Roselli, S., Benessy, F., Antignac, C. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349-354. <https://doi.org/10.1038/74166>
4. Caridi, G., Bertelli, R., Carrea, A., Ghiggeri, G. M. (2001) Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12, 2742-2746. <https://doi.org/10.1681/ASN.V12122742>
5. Caridi, G., Bertelli, R., Scolari, F., Ghiggeri, G. M. (2003) Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int. 64, 365. <https://doi.org/10.1046/j.1523-1755.2003.00084.x>
6. Caridi, G., Gigante, M., Ravani, P., Ghiggeri, G. M. (2009) Clinical features and long term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. Clin. J. Am. Soc. Nephrol. 4, 1065-1072. <https://doi.org/10.2215/CJN.03910808>
7. DiDuca, M., Oleggini, R., Sanna-Cherchi, S., Ghiggeri, G. M. (2006) Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases. Kidney Int. 70, 1332-1341. <https://doi.org/10.1038/sj.ki.5001767>
8. Dusel, J. A., Burdon, K. P., Hicks, P. J., Freedman, B. I. (2005) Identification of podocin (NPHS2) gene mutations in African Americans with nondiabetic end-stage renal disease. Kidney Int. 68, 256-262. <https://doi.org/10.1111/j.1523-1755.2005.00400.x>
9. Franceschini, N., North, K. E., Kopp, J. B., Winkler, C. (2006) NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: A HuGE review. Genet Med. 8, 63-75. <https://doi.org/10.1097/01.gim.0000200947.09626.1c>
10. He, N., Zahirieh, A., Mei, Y., Pei, Y. (2007) Recessive NPHS2 mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 2, 31-37. <https://doi.org/10.2215/CJN.02690806>
11. Hinkes, B., Vlangos, C., Heeringa, S., Hildebrandt, F. (2008) Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 19, 365-371. <https://doi.org/10.1681/ASN.2007040452>
12. Karle, S. M., Uetz, B., Ronner, V., Fuchshuber, A. (2002) Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 13, 388-393. <https://doi.org/10.1681/ASN.V132388>
13. Korbet, S. M. (2002) Treatment of primary focal segmental glomerulosclerosis. Kidney Int. 62, 2301-2310. <https://doi.org/10.1046/j.1523-1755.2002.00674.x>
14. Machuca, E., Hummel, A., Nevo, F., Dantal, J., Antignac, C. (2009) Clinical and epidemiological assessment of steroidresistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int. 75, 727-735. <https://doi.org/10.1038/ki.2008.650>
15. McKenzie, L. M., Hendrickson, S. L., Briggs, W. A., Winkler, C. A. (2007) NPHS2 variation in sporadic focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 18, 2987-2995. <https://doi.org/10.1681/ASN.2007030319>
16. Mele, C., Iatropoulos, P., Donadelli, R., Calabria, A., Maranta, R., Cassis, P., Buelli, S., Tomasoni, S., Piras, R., Krendel, M., Bettoni, S., Morigi, M., Delledonne, M., Pecoraro, C., Abbate, I., Capobianchi. M. R., Hildebrandt, F., Otto, E., Schaefer, F., Macciardi, F., Ozaltin, F., Emre, S., Ibsirlioglu, T., Benigni, A., Remuzzi, G., Noris, M., PodoNet Consortium (2011) MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N. Engl. J. Med. 365, 295-306. <https://doi.org/10.1056/NEJMoa1101273>
17. Monteiro, E. J., Pereira, A. C., Pereira, A. B., Mastroianni-Kirsztajn, G. (2006) NPHS2 mutations in adult patients with primary focal segmental glomerulosclerosis. J. Nephrol. 19, 366-371.
18. Ozaltin, F., Ibsirlioglu, T., Taskiran, E. Z., Baydar, D. E., Kaymaz, F., Buyukcelik, M., Kilic, B. D., Balat, A., Iatropoulos, P., Asan, E., Akarsu, N. A., Schaefer, F.,Yilmaz, E., Bakkaloglu, A., PodoNet Consortium10 (2011) Disruption of PTPRO causes childhood-onset nephrotic syndrome. Am. J. Hum. Genet. 89, 139-147. <https://doi.org/10.1016/j.ajhg.2011.05.026>
19. Pereira, A. C., Pereira, A. B., Mota, G. F., Krieger, J. E. (2004) NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int. 65, 1026-1030. <https://doi.org/10.1111/j.1523-1755.2004.00479.x>
20. Ruf, R. G., Lichtenberger, A., Karle, S. M., Hildebrandt, F. (2004) Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment on nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722-732. <https://doi.org/10.1097/01.ASN.0000113552.59155.72>
21. Santín, S., Tazón-Vega, B., Silva, I., Ars, E. (2011) Clinical value of NPHS2 analysis in earlyand adult-onset steroidresistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 6, 344-354. <https://doi.org/10.2215/CJN.03770410>
22. Tonna, S. J., Needham, A., Polu, K., Pollak, M. R. (2008) NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol. 9, 13. <https://doi.org/10.1186/1471-2369-9-13>
23. Tsukaguchi, H., Sudhakar, A., Le, T. C. (2002) NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J. Clin. Invest. 110, 1659-1666. <https://doi.org/10.1172/JCI0216242>
24. Weber, S., Gribouval, O., Esquivel, E. L. (2004) NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 66, 571-579. <https://doi.org/10.1111/j.1523-1755.2004.00776.x>
25. Yu, Z., Ding, J., Huang, J., Yang, J. (2005) Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome. Nephrol. Dial. Transplant. 20, 902-908. <https://doi.org/10.1093/ndt/gfh769>
26. Zhang, S. Y., Marlier, A., Gribouval, O. (2004) In vivo expression of podocyte slit diaphragm-associated proteins in nephrotic patients with NPHS2 mutations. Kidney Int. 66, 945-954. <https://doi.org/10.1111/j.1523-1755.2004.00840.x>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive